Glycogen storage disease

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Group of inherited metabolic disorders affecting glycogen metabolism

Glycogen storage disease (GSD) refers to a group of inherited metabolic disorders that affect the body's ability to store and utilize glycogen, a form of glucose stored in the liver and muscles. These disorders are caused by deficiencies in the enzymes responsible for glycogen synthesis or breakdown, leading to an accumulation or deficiency of glycogen in various tissues.

Classification

Glycogen storage diseases are classified based on the specific enzyme deficiency and the affected tissue. The most common types include:

• Type I (Von Gierke's disease): Caused by a deficiency of the enzyme glucose-6-phosphatase, leading to severe hypoglycemia and accumulation of glycogen in the liver and kidneys.
• Type II (Pompe disease): Results from a deficiency of acid alpha-glucosidase, affecting the heart and skeletal muscles.
• Type III (Cori disease): Due to a deficiency in the debranching enzyme, leading to abnormal glycogen structure and accumulation in the liver and muscles.
• Type IV (Andersen's disease): Caused by a deficiency in the branching enzyme, resulting in abnormal glycogen that can lead to liver cirrhosis.
• Type V (McArdle's disease): Characterized by a deficiency of muscle phosphorylase, affecting muscle metabolism and causing exercise intolerance.
• Type VI (Hers disease): Due to a deficiency of liver phosphorylase, leading to mild hypoglycemia and hepatomegaly.

Pathophysiology

Glycogen storage diseases result from mutations in genes encoding enzymes involved in glycogen metabolism. These mutations lead to either an accumulation of glycogen in tissues or an inability to mobilize glycogen stores, resulting in various clinical manifestations. The specific symptoms depend on the type of GSD and the tissues affected.

Clinical Manifestations

The clinical presentation of glycogen storage diseases varies widely depending on the type and severity of the enzyme deficiency. Common symptoms include:

• Hypoglycemia
• Hepatomegaly
• Muscle weakness and cramps
• Cardiomyopathy
• Growth retardation
• Lactic acidosis

Diagnosis

Diagnosis of glycogen storage diseases typically involves a combination of clinical evaluation, biochemical tests, and genetic analysis. Key diagnostic steps include:

• Measurement of blood glucose and lactate levels
• Liver function tests
• Muscle biopsy and enzyme assays
• Genetic testing to identify specific mutations

Management

Management of glycogen storage diseases focuses on controlling symptoms and preventing complications. Treatment strategies may include:

• Dietary modifications to maintain normal blood glucose levels
• Enzyme replacement therapy, particularly for Pompe disease
• Liver transplantation in severe cases
• Physical therapy to manage muscle symptoms

Prognosis

The prognosis for individuals with glycogen storage diseases varies depending on the type and severity of the disorder. Early diagnosis and appropriate management can improve outcomes and quality of life for many patients.

See also

• Metabolic disorder
• Enzyme deficiency
• Genetic disorder